Stage 4S Neuroblastoma Completed Phase 3 Trials for Filgrastim (DB00099)

Indication	Status	Phase
DBCOND0029574 (Stage 4S Neuroblastoma)	Completed	3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00567567	Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma	Treatment	Beta-D-Glucose (DB02379) Carboplatin (DB00958) Chloride ion (DB14547) Cisplatin (DB00515) Cyclophosphamide (DB00531) Doxorubicin (DB00997) Etoposide (DB00773) Filgrastim (DB00099) Isotretinoin (DB00982) Mechlorethamine (DB00888) Platinum (DB12257) Thiotepa (DB04572) Topotecan (DB01030) Tromethamine (DB03754) Vincristine (DB00541)